Ted W. Love - Jul 1, 2016 Form 4/A - Amendment Insider Report for Global Blood Therapeutics, Inc. (GBT)

Role: President and CEO, Director
Signature: /s/ Miguel Carrillo, as Attorney-in-Fact
Stock symbol: GBT
Transactions as of: Jul 1, 2016
Transactions value $: -$84,391
Form type: 4/A - Amendment
Date filed: 1/6/2022, 05:57 PM
Date Of Original Report: Dec 16, 2016
Next filing: May 18, 2021

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	GBT	Common Stock	Disposed to Issuer	-$84.4K	-24.8K	-2.17%	$3.40^*	1.12M	Jul 1, 2016	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Remarks:

On December 16, 2016, the Reporting Person filed a Form 4 which reported an incorrect ending balance of direct holdings due to an administrative error. The correct ending balance should have been 1,117,815 shares, instead of 1,139,815 shares as previously reported. The indirect holdings on the original filing were correct. The Reporting Person's Section 16 filings since December 16, 2016 also reported an incorrect ending balance of his direct holdings due to such administrative error.